发明名称 Multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging
摘要 A multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging.
申请公布号 US9623127(B2) 申请公布日期 2017.04.18
申请号 US201114358818 申请日期 2011.11.08
申请人 CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;HOSPICES CIVILS DE LYON;UNIVERSITE DE STRASBOURG;UNIVERSITE CLAUDE BERNARD LYON 1 发明人 Felder-Flesch Delphine;Billotey Claire;Lamanna Giuseppe;Janier Marc;Kriza David
分类号 A61K51/04;A61K49/18;C07B59/00;A61K49/00;A61K49/12 主分类号 A61K51/04
代理机构 Young & Thompson 代理人 Young & Thompson
主权项 1. Functionalized dendritic nanoprobes of the following formula (I)wherein: for generation 1, R4 and R6 represent independently from each other a chain composed of oligoethyleneglycol patterns, at least one of said oligoethyleneglycol chains being functionalized at its extremity by a group chosen among a fluorophore, or a biocompatible dye, and R5 represents an hydrogen atom or a chain composed of oligoethyleneglycol patterns, said chain being optionally functionalized at its extremity by a group chosen among or a biocompatible dye, for higher generations, R5 represents an hydrogen atom and R4 and R6 represent a dendritic structure (D)m comprising at least one ether of benzyl alcohol, said benzyl being substituted either at positions 3, 4, and 5, or at positions 3 and 5, by chains composed of oligoethyleneglycol patterns, at least one of said oligoethyleneglycol chains being functionalized at its extremity by a group chosen among a fluorophore, or a biocompatible dye, and m=1, 2 or 4, X represents a group of the following formula (II): wherein p is from 3 to 6 and wherein the mean diameter of the nanoprobe is from 2 to 60 nm.
地址 Paris FR